CORE
CO
nnecting
RE
positories
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Research partnership
About
About
About us
Our mission
Team
Blog
FAQs
Contact us
Community governance
Governance
Advisory Board
Board of supporters
Research network
Innovations
Our research
Labs
Filters
1 research outputs found
Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients
Author
Mark Temper
Michal Lotem
+18 more
Hovav Nechushtan
Eli Pikarsky
Daniela Katz
Tamar Peretz
Beatrice Uziely
Shai Rosenberg
Yael Goldberg
Yakir Rottenberg
Amichai Meirovitz
Ayala Hubert
Hanoch Goldshmidt
Iris Fried
Amir Sonnenblick
Eli Sapir
David Edelman
Ruth Finklstein
Aviad Zick
Alexander Lossos
Publication venue
Publication date
01/05/2017
Field of study
No full text
Crossref
No full text
